4245.20 +12.20 (0.29%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
4158.95
Today’s High
4259.2
52 Week Low
3365.9
52 Week High
5015.45
4251.60 +20.10 (0.48%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
4158
Today’s High
4259.8
52 Week Low
3361.55
52 Week High
5016.55
Key Metrics
- Market Cap (In Cr) 60842.48
- Beta 0.95
- Div. Yield (%) 0.28
- P/B 10.82
- TTM P/E 75.07
- Peg Ratio 5.51
- Sector P/E 39.92
- D/E 0.67
- Open Price 4235.1
- Prev Close 4233
Analysis
Price Analysis
-
1 Week0.17%
-
3 Months-3.72%
-
6 Month-3.74%
-
YTD-5.5%
-
1 Year-9.32%
Risk Meter
- 25% Low risk
- 25% Moderate risk
- 25% Balanced Risk
- 25% High risk
- 25% Extreme risk
Recos
22 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 0
- Hold
- 0
- Buy
- 13
- Strong Buy
- 9
Apollo Hospitals Enterprise News
'Rakesh Jhunjhunwala's most valuable and profitable investment advice ever…'
1 min read . 23 Aug 2022
₹12 to ₹4,124: Multibagger stock turns ₹1 lakh to ₹3.24 Cr in 23 years
5 min read . 21 Aug 2022Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 14662.6
- Selling/ General/ Admin Expenses Total
- 4882.5
- Depreciation/ Amortization
- 600.1
- Other Operating Expenses Total
- 17.5
- Total Operating Expense
- 12780.1
- Operating Income
- 1882.5
- Net Income Before Taxes
- 1578.1
- Net Income
- 1055.6
- Diluted Normalized EPS
- 59.34
- Period
- 2022
- Total Assets
- 13218.13
- Total Liabilities
- 7595.03
- Total Equity
- 5623.1
- Tangible Book Valueper Share Common Eq
- 318.21
- Period
- 2022
- Cashfrom Operating Activities
- 1728.6
- Cashfrom Investing Activities
- -778.2
- Cashfrom Financing Activities
- -792.6
- Net Changein Cash
- 157.8
- Period
- 2021
- Total Revenue
- 10560
- Selling/ General/ Admin Expenses Total
- 3663.8
- Depreciation/ Amortization
- 572.5
- Other Operating Expenses Total
- 71.7
- Total Operating Expense
- 9932.2
- Operating Income
- 627.8
- Net Income Before Taxes
- 220.7
- Net Income
- 150.4
- Diluted Normalized EPS
- 8.2
- Period
- 2021
- Total Assets
- 11416.7
- Total Liabilities
- 6814.2
- Total Equity
- 4602.5
- Tangible Book Valueper Share Common Eq
- 288.02
- Period
- 2021
- Cashfrom Operating Activities
- 1256.9
- Cashfrom Investing Activities
- -872.3
- Cashfrom Financing Activities
- -340.1
- Net Changein Cash
- 44.5
- Period
- 2020
- Total Revenue
- 11246.8
- Selling/ General/ Admin Expenses Total
- 4117.4
- Depreciation/ Amortization
- 619.1
- Other Operating Expenses Total
- 39.5
- Total Operating Expense
- 10077.2
- Operating Income
- 1169.6
- Net Income Before Taxes
- 660
- Net Income
- 454.8
- Diluted Normalized EPS
- 23.48
- Period
- 2020
- Total Assets
- 11338.4
- Total Liabilities
- 7999.3
- Total Equity
- 3339.1
- Tangible Book Valueper Share Common Eq
- 211.19
- Period
- 2020
- Cashfrom Operating Activities
- 1292.8
- Cashfrom Investing Activities
- -288.8
- Cashfrom Financing Activities
- -909.5
- Net Changein Cash
- 94.5
- Period
- 2019
- Total Revenue
- 9617.44
- Selling/ General/ Admin Expenses Total
- 3831.59
- Depreciation/ Amortization
- 394.91
- Other Operating Expenses Total
- 52.06
- Total Operating Expense
- 8940.04
- Operating Income
- 677.4
- Net Income Before Taxes
- 373.54
- Net Income
- 236.05
- Diluted Normalized EPS
- 17.02
- Period
- 2019
- Total Assets
- 9183.07
- Total Liabilities
- 5849.6
- Total Equity
- 3333.47
- Tangible Book Valueper Share Common Eq
- 212.2
- Period
- 2019
- Cashfrom Operating Activities
- 904.95
- Cashfrom Investing Activities
- -710.56
- Cashfrom Financing Activities
- -214.51
- Net Changein Cash
- -20.12
- Period
- 2018
- Total Revenue
- 8243.47
- Selling/ General/ Admin Expenses Total
- 3364.7
- Depreciation/ Amortization
- 358.41
- Other Operating Expenses Total
- 42.33
- Total Operating Expense
- 7798.72
- Operating Income
- 444.74
- Net Income Before Taxes
- 171.46
- Net Income
- 117.42
- Diluted Normalized EPS
- 8.81
- Period
- 2018
- Total Assets
- 8612.83
- Total Liabilities
- 5361.32
- Total Equity
- 3251.5
- Tangible Book Valueper Share Common Eq
- 205.88
- Period
- 2018
- Cashfrom Operating Activities
- 536.96
- Cashfrom Investing Activities
- -404.91
- Cashfrom Financing Activities
- -108.5
- Net Changein Cash
- 23.55
- Period
- 2017
- Total Revenue
- 7255.7
- Selling/ General/ Admin Expenses Total
- 2891.26
- Depreciation/ Amortization
- 313.42
- Other Operating Expenses Total
- 24.74
- Total Operating Expense
- 6828.91
- Operating Income
- 426.79
- Net Income Before Taxes
- 222.08
- Net Income
- 220.99
- Diluted Normalized EPS
- 16.08
- Period
- 2017
- Total Assets
- 8119.29
- Total Liabilities
- 4806.08
- Total Equity
- 3313.2
- Tangible Book Valueper Share Common Eq
- 211.26
- Period
- 2017
- Cashfrom Operating Activities
- 622.55
- Cashfrom Investing Activities
- -1151.88
- Cashfrom Financing Activities
- 476.96
- Net Changein Cash
- -52.37
- Period
- 2022-09-30
- Total Revenue
- 4251.07
- Selling/ General/ Admin Expenses Total
- 540.84
- Depreciation/ Amortization
- 155.01
- Other Operating Expenses Total
- 973
- Total Operating Expense
- 3840.71
- Operating Income
- 410.36
- Net Income Before Taxes
- 327.07
- Net Income
- 203.99
- Diluted Normalized EPS
- 14.19
- Period
- 2022-09-30
- Total Assets
- 13974.84
- Total Liabilities
- 7981.97
- Total Equity
- 5992.87
- Tangible Book Valueper Share Common Eq
- 344.25
- Period
- 2022-09-30
- Period
- 2022-06-30
- Total Revenue
- 3795.6
- Selling/ General/ Admin Expenses Total
- 447.42
- Depreciation/ Amortization
- 147.78
- Other Operating Expenses Total
- 905.32
- Total Operating Expense
- 3452.64
- Operating Income
- 342.96
- Net Income Before Taxes
- 254.28
- Net Income
- 317.11
- Diluted Normalized EPS
- 22.05
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 3546.39
- Selling/ General/ Admin Expenses Total
- 446.6
- Depreciation/ Amortization
- 166.4
- Other Operating Expenses Total
- 820.89
- Total Operating Expense
- 3249.59
- Operating Income
- 296.8
- Net Income Before Taxes
- 232.72
- Net Income
- 90.12
- Diluted Normalized EPS
- 6.27
- Period
- 2022-03-31
- Total Assets
- 13218.13
- Total Liabilities
- 7595.03
- Total Equity
- 5623.1
- Tangible Book Valueper Share Common Eq
- 318.21
- Period
- 2022-03-31
- Period
- 2021-12-31
- Total Revenue
- 3638.93
- Selling/ General/ Admin Expenses Total
- 439.6
- Depreciation/ Amortization
- 148.99
- Other Operating Expenses Total
- 788.78
- Total Operating Expense
- 3200.9
- Operating Income
- 438.03
- Net Income Before Taxes
- 361.51
- Net Income
- 228.37
- Diluted Normalized EPS
- 15.88
- Period
- 2021-12-31
- Period
- 2021-12-31
- Period
- 2021-09-30
- Total Revenue
- 3717.07
- Selling/ General/ Admin Expenses Total
- 456.82
- Depreciation/ Amortization
- 144.76
- Other Operating Expenses Total
- 772.93
- Total Operating Expense
- 3246.84
- Operating Income
- 470.23
- Net Income Before Taxes
- 380.47
- Net Income
- 247.82
- Diluted Normalized EPS
- 17.24
- Period
- 2021-09-30
- Total Assets
- 12910.09
- Total Liabilities
- 7605.42
- Total Equity
- 5304.67
- Tangible Book Valueper Share Common Eq
- 297.01
- Period
- 2021-09-30
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Technical
Moving Average
SMA
- 5 Day4247.65
- 10 Day4270.77
- 20 Day4320.66
- 50 Day4530.78
- 100 Day4467.25
- 300 Day4257.37
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Apollo Hospitals Enterprise
- 4245.2
- 12.2
- 0.29
- 5015.45
- 3365.9
- 61290.37
- Max Healthcare Institute
- 436.4
- -4
- -0.91
- 482.5
- 306
- 42833.26
- Fortis Healthcare
- 278
- -0.3
- -0.11
- 324.8
- 219.8
- 20987.84
- Dr. Lal Pathlabs
- 1890.1
- -129.8
- -6.43
- 3270.3
- 1805.1
- 17012.09
- Narayana Hrudayalaya
- 715.15
- -6.35
- -0.88
- 810.15
- 589.9
- 14461.62
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Apollo Hospitals Enterprise
- 71.84
- 10.9
- 10.6
- 3.56
- Max Healthcare Institute
- 69.55
- 6.81
- -
- -
- Fortis Healthcare
- 69.86
- 3.4
- -2.77
- -1.42
- Dr. Lal Pathlabs
- 49.31
- 11.26
- 24.34
- 17.17
- Narayana Hrudayalaya
- 42
- 9.78
- 9.95
- 3.83
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 70.67%
- 101,607,045
- SCHRODER INTERNATIONAL SELECTION FUND ASIAN OPPORTUNITIES
- 1.9%
- 2,737,719
- VERITAS FUNDS PLC ON BEHALF OF VERITAS ASIAN FUND
- 1.41%
- 2,024,329
- TOUCHSTONE STRATEGIC TRUST - TOUCHSTONE SANDS CAPITAL EMERGING MARKETS GROWTH FUND
- 1.3%
- 1,865,136
- JP MORGAN FUNDS
- 1.05%
- 1,516,901
- Others
- 39.23%
- 56,401,282
- AXIS MUTUAL FUND TRUSTEE LIMITED
- 1.65%
- 2,373,570
- SBI NIFTY 50 ETF
- 1.64%
- 2,363,410
- ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED
- 1.54%
- 2,208,283
- HDFC TRUSTEE COMPANY LIMITED
- 1.16%
- 1,666,242
- Others
- 4.2%
- 6,055,055
- LIFE INSURANCE CORPORATION OF INDIA
- 2%
- 2,881,613
- HDFC LIFE INSURANCE COMPANY LIMITED
- 1.02%
- 1,460,752
- Others
- 2.49%
- 3,594,803
- Others
- 3.89%
- 5,589,931
- Others
- 3.05%
- 4,381,680
- Others
- 0.81%
- 1,167,569
- Others
- 0.7%
- 1,001,848
- Bodies Corporate
- 0.34%
- 487,987
- Clearing Members
- 0.1%
- 145,218
- Trusts
- 0.1%
- 138,367
- Unclaimed or Suspense or Escrow Account
- 0.09%
- 132,396
- HUF
- 0.05%
- 66,149
- LLP
- 0.01%
- 15,995
- Foreign Portfolio Investor (Category - III)
- 0%
- 2,883
- Director or Director's Relatives
- 0%
- 1,150
- Employees
- 0%
- 121
- Others
- 0.31%
- 451,666
- Others
- 0.24%
- 348,418
- Others
- 0.23%
- 323,708
- Others
- 0.09%
- 131,345
- Others
- 0.05%
- 69,995
- Others
- 0%
- 1,398
- Others
- 0%
- 122
- Others
- 0%
- 4
- Promoter & Promoter Group Shareholding
- 29.33%
- 42,177,612
- M/s. PCR Investments Ltd
- 18.93%
- 27,223,124
- M/s. Indian Hospitals Corporation Ltd
- 0.04%
- 61,704
- M/s. Obul Reddy Investments Pvt Ltd
- 0.01%
- 11,200
- Ms. Suneeta Reddy
- 3.36%
- 4,834,305
- Ms. Sangita Reddy
- 1.69%
- 2,432,508
- Ms. Shobana Kamineni
- 1.56%
- 2,239,952
- Mr. K Vishweshwar Reddy
- 1.1%
- 1,577,350
- Ms. Preetha Reddy
- 0.73%
- 1,043,915
- Mr. Karthik Anand
- 0.24%
- 345,238
- Mr. Harshad Reddy
- 0.23%
- 327,900
- Ms. Sindoori Reddy
- 0.22%
- 318,600
- Ms. Anuspala Kamineni
- 0.18%
- 259,174
- Dr. Prathap C Reddy
- 0.17%
- 245,464
- Mr. Konda Anindith Reddy
- 0.16%
- 230,200
- Mr. Konda Vishwajit Reddy
- 0.15%
- 222,300
- Ms. Upasana Konidela
- 0.15%
- 217,276
- Mr. Puansh Kamineni
- 0.15%
- 212,201
- Ms. Sucharitha P Reddy
- 0.12%
- 169,800
- Mr. Konda Viraj Madhav Reddy
- 0.12%
- 168,224
- Mr. Dwaraknath Reddy
- 0.01%
- 18,000
- Mr. Aditya Reddy
- 0.01%
- 10,200
- Mr. Vijay Kumar Reddy
- 0.01%
- 8,957
- Mr. Anil Kamineni
- 0%
- 20
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-Feb-23
- Quarterly Results
- 30-Nov-22
- Others
- 10-Nov-22
- Quarterly Results
- 11-Aug-22
- Quarterly Results
- 25-May-22
- Audited Results & Dividend
- 11-Feb-22
- Quarterly Results
- 12-Nov-21
- Quarterly Results
- 13-Aug-21
- Quarterly Results
- 23-Jun-21
- Audited Results & Dividend
- 12-Feb-21
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 31-Aug-21
- 22-Jul-21
- AGM
- 16-Aug-21
- 13-Jul-21
- POM
- 04-May-21
- 06-Apr-21
- POM
- -
- 25-May-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 25-May-22
- -
- 18-Aug-22
- 11.75
- 23-Jun-21
- -
- 18-Aug-21
- 3
No recent bonus announcements.
No recent splits available.
No recent rights issue declared.
Company Profile
ABOUT Apollo Hospitals Enterprise
- Industry Healthcare Facilities
- ISIN INE437A01024
- BSE Code 508869
- NSE Code APOLLOHOSP
Apollo Hospitals Enterprise Limited is an India-based company, which is engaged in providing comprehensive hospital services. The Company provides and sells pharma and wellness products through a network of pharmacies. The principal activities of the Company include the operation of multidisciplinary private hospitals, clinics and pharmacies. The Company operates through two segments: Healthcare and Retail Pharmacy. The Healthcare segment represents hospitals and hospital-based pharmacies. The Retail Pharmacy segment represents the business of procurement and distribution of pharmaceutical, fast-moving consumer goods (FMCG) and private label products. The Company has approximately 10209 beds across approximately 71 Hospitals, 24118 pharmacies in 20 states and four union territories.
MANAGEMENT
- Prathap Reddy Executive Chairman of the Board, Founder
- Shobana Kamineni Executive Vice Chairman of the Board
- Preetha Reddy Executive Vice Chairman of the Board
- Krishnan Akhileswaran Chief Financial Officer
- K. Hariprasad President - Hospitals
- Dinesh Madhavan President - Group Oncology and International
- S. M. Krishnan Senior Vice President - Finance, Compliance Officer, Company Secretary
- Sangita Reddy Joint Managing Director, Executive Director
- Suneeta Reddy Managing Director, Executive Director
- Anupam Sibal Group Medical Director
Company Summary
APOLLO HOSPITALS ENTERPRISE SUMMARY
Apollo Hospitals Enterprise is trading 0.29% upper at Rs 4245.20 as compared to its last closing price. Apollo Hospitals Enterprise has been trading in the price range of 4259.2 & 4158.95. Apollo Hospitals Enterprise has given -5.5% in this year & 0.17% in the last 5 days.
Apollo Hospitals Enterprise has TTM P/E ratio 75.07 as compared to the sector P/E of 39.92. There are 22 analysts who have initiated coverage on Apollo Hospitals Enterprise. There are 9 analysts who have given it a strong buy rating & 13 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.
The company posted a net profit of 203.99 Crores in its last quarter.
Listed peers of Apollo Hospitals Enterprise include Apollo Hospitals Enterprise (0.29%), Max Healthcare Institute (-0.91%), Fortis Healthcare (-0.11%) etc.
Apollo Hospitals Enterprise has a 29.33% promoter holding & 70.67% public holding.
FAQs about Apollo Hospitals Enterprise
Apollo Hospitals Enterprise is trading at 4245.20 as on 3 Feb, 2023 3:29:25 PM. This is 0.29% upper as compared to its previous closing price of 4233
The market capitalization of Apollo Hospitals Enterprise is 60842.48 Cr as on 3 Feb, 2023 3:29:25 PM.
The average broker rating on Apollo Hospitals Enterprise is Strong Buy. The breakup of analyst rating is given below -
- 0 analysts have given a strong sell rating
- 0 analysts have given a sell rating
- 0 analysts have given a hold rating
- 13 analysts have given a buy rating
- 9 analysts have given a strong buy rating
The 52 wk high for Apollo Hospitals Enterprise is 5015.45 whereas the 52 wk low is 3365.9
Apollo Hospitals Enterprise can be analyzed on the following key metrics -
- TTM P/E: 75.07
- Sector P/E: 39.92
- Dividend Yield: 0.28%
- D/E ratio: -
Apollo Hospitals Enterprise reported a net profit of 1055.6 Cr in 2022.
